Insider Trading History of Doherty Catherine T.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Doherty Catherine T. since 2012. This trader's CIK number is 1520897. At the time of last reporting, Doherty Catherine T. was the EVP, Regional Businesses of Quest Diagnostics Inc. (stock ticker symbol DGX). Also see all insider trading activities at Quest Diagnostics Inc.



Yearly summary of insider trading at Quest Diagnostics Inc (DGX) by Doherty Catherine T.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 DGX 0 $0 6,194 $1,077,308 0 $0
2024 DGX 0 $0 39,847 $6,236,606 33,103 $3,428,477
2023 DGX 0 $0 7,714 $1,085,728 0 $0
2022 DGX 0 $0 50,547 $7,377,906 40,765 $3,531,471
2021 DGX 0 $0 46,101 $7,042,354 37,565 $3,598,539
2020 DGX 0 $0 62,455 $6,905,859 58,392 $3,883,651
2019 DGX 0 $0 66,382 $6,013,744 60,492 $4,305,215
2018 DGX 0 $0 29,067 $3,006,489 21,294 $1,110,801
2017 DGX 0 $0 148,539 $14,566,338 139,762 $7,739,368
2016 DGX 0 $0 76,884 $5,856,714 71,001 $3,873,577
2014 DGX 0 $0 48,667 $2,974,821 48,667 $2,453,695
2013 DGX 0 $0 76,334 $4,661,824 76,334 $3,598,108
2012 DGX 0 $0 40,000 $2,404,320 40,000 $2,089,400


Insider trading of Quest Diagnostics Inc (DGX) by Doherty Catherine T.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-05 DGX Sale 5,370 174.13 935,078
2025-02-27 DGX Sale 824 172.61 142,230
2024-11-27 DGX Option Ex 33,103 103.57 3,428,477
2024-11-27 DGX Sale 33,103 162.64 5,383,838
2024-02-28 DGX Sale 5,557 126.57 703,349
2024-02-29 DGX Sale 1,187 125.88 149,419
2023-03-07 DGX Sale 5,307 140.55 745,898
2023-03-03 DGX Sale 717 140.63 100,831
2023-02-24 DGX Sale 1,690 141.42 238,999
2022-11-28 DGX Sale 40,765 149.15 6,079,895
2022-11-28 DGX Option Ex 40,765 86.63 3,531,471
2022-03-08 DGX Sale 7,032 135.21 950,796
2022-02-24 DGX Sale 2,750 126.26 347,215
2021-11-29 DGX Sale 37,565 155.67 5,847,630
2021-11-29 DGX Option Ex 37,565 95.80 3,598,539
2021-05-07 DGX Sale 8,536 139.96 1,194,724
2020-09-02 DGX Option Ex 58,392 66.51 3,883,651
2020-09-02 DGX Sale 58,392 110.85 6,472,578
2020-03-11 DGX Sale 2,501 104.25 260,729
2020-02-27 DGX Sale 789 109.02 86,016
2020-02-26 DGX Sale 368 111.09 40,881
2020-02-25 DGX Sale 405 112.73 45,655
2019-04-04 DGX Option Ex 60,492 71.17 4,305,215
2019-04-04 DGX Sale 66,382 90.59 6,013,744
2018-03-05 DGX Sale 5,556 101.00 561,156
2018-02-27 DGX Sale 1,248 104.10 129,916
2018-02-28 DGX Sale 572 104.99 60,054
2018-02-26 DGX Sale 397 102.74 40,787
2018-01-24 DGX Option Ex 21,294 52.16 1,110,801
2018-01-24 DGX Sale 21,294 104.00 2,214,576
2017-06-19 DGX Sale 59,762 107.84 6,444,853
2017-06-19 DGX Option Ex 59,762 57.02 3,407,928
2017-03-03 DGX Sale 6,028 98.29 592,492
2017-03-02 DGX Sale 1,134 98.25 111,415
2017-02-15 DGX Sale 1,615 94.65 152,858
2017-01-30 DGX Option Ex 80,000 54.14 4,331,440
2017-01-30 DGX Sale 80,000 90.81 7,264,720
2016-05-27 DGX Option Ex 47,334 56.23 2,661,827
2016-05-27 DGX Sale 47,334 77.27 3,657,308
2016-04-25 DGX Option Ex 23,667 51.20 1,211,750
2016-04-25 DGX Sale 29,550 74.43 2,199,406
2014-11-03 DGX Option Ex 23,667 47.49 1,123,945
2014-11-03 DGX Sale 23,667 62.19 1,471,921
2014-08-08 DGX Option Ex 25,000 53.19 1,329,750
2014-08-08 DGX Sale 25,000 60.12 1,502,900
2013-09-17 DGX Sale 27,621 62.00 1,712,502
2013-09-16 DGX Sale 15,713 62.00 974,206
2013-09-17 DGX Option Ex 27,621 52.24 1,443,059
2013-09-16 DGX Option Ex 15,713 52.24 820,925
2013-08-14 DGX Sale 33,000 59.85 1,975,116
2013-08-14 DGX Option Ex 33,000 40.43 1,334,124
2012-08-08 DGX Option Ex 40,000 52.23 2,089,400
2012-08-08 DGX Sale 40,000 60.11 2,404,320

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doherty Catherine T. (EVP, Regional Businesses of Quest Diagnostics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.